NCT01448902View on ClinicalTrials.gov

A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Allergic Rhinitis
Interventions
DRUG

OC000459

OC000459 200mg bid for 8 days

DRUG

Placebo

Placebo bid for 8 days

Trial Locations (1)

Unknown

Vienna Challenge Chamber, Vienna

Sponsors

Lead Sponsor

Oxagen Ltd
All Listed Sponsors
lead

Oxagen Ltd

INDUSTRY